Source-grounded facts extracted from CENTENE CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Lauren Tyler was elected as Director at CENTENE CORP.
“Effective June 19, 2026, the Board of Directors (the Board) of Centene Corporation (the Company) increased the size of the Board from 9 to 10 and elected Lauren Tyler to the Board to fill the resulting vacancy”
CENTENE CORP shareholders rejected Shareholder proposal regarding an independent board chairman at the 2026-05-12 meeting.
“4. Shareholder proposal regarding an independent board chairman. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes 72,839,667 308,562,931 1,158,361 30,407,100”
CENTENE CORP shareholders approved Ratification of the appointment of KPMG LLP at the 2026-05-12 meeting.
“3. Ratification of the appointment of KPMG LLP. The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026, was ratified based upon the following votes: For Against Abstain 390,477,647 22,337,787 152,625”
CENTENE CORP shareholders approved Non-binding advisory vote on executive compensation at the 2026-05-12 meeting.
“2. Non-binding advisory vote on executive compensation. The Company's executive compensation was approved by a non-binding advisory vote based upon the following votes: For Against Abstain Broker Non-Votes 349,896,589 31,993,126 671,244 30,407,100”
CENTENE CORP reported first quarter ended March 31, 2026 results: revenue $ 49,944, EPS $ 3.11. Guidance raised.
“announced today its financial results for the first quarter ended March 31, 2026. In summary, the 2026 first quarter results were as follows: Total revenues (in millions) $ 49,944 Premium and service revenues (in millions) $ 44,655 Health benefits ratio 87.3 % SG&A expense ratio 7.6 % Adjusted SG&A expense ratio (1) 7.6 % GAAP diluted earnings per share $”
CENTENE CORP incurred term loan of $2,000,000,000 with Wells Fargo Bank, National Association (administrative agent) and the lenders at a fluctuating rate per annum equal to a benchmark rate applicable to the currenc maturing March 5, 2030.
“The New Credit Agreement provides for (i) a revolving credit facility in the principal amount of $4,000,000,000 (the Revolving Credit Facility) and (ii) a term loan facility in the principal amount of $2,000,000,000 (the Term Loan Facility and, together with the Revolving Credit Facility, the Senior Unsecured Credit Facility).”
CENTENE CORP incurred revolving credit of $4,000,000,000 with Wells Fargo Bank, National Association (administrative agent) and the lenders at a fluctuating rate per annum equal to a benchmark rate applicable to the currenc maturing March 5, 2030.
“The New Credit Agreement provides for (i) a revolving credit facility in the principal amount of $4,000,000,000 (the Revolving Credit Facility) and (ii) a term loan facility in the principal amount of $2,000,000,000 (the Term Loan Facility and, together with the Revolving Credit Facility, the Senior Unsecured Credit Facility).”
Kenneth J. Fasola departed as President at CENTENE CORP.
“On November 8, 2024, Kenneth J. Fasola, President of Centene Corporation (the "Company"), informed the Company that he intends to retire from the Company on July 1, 2025.”
Lori J. Robinson departed as Director at CENTENE CORP.
“On September 25, 2024, Director Lori J. Robinson notified Centene Corporation (the “Company”) of her decision not to stand for re-election when her term expires at the Company’s 2025 Annual Meeting.”
Thomas Greco was elected as Director at CENTENE CORP.
“elected Thomas Greco to the Board to fill the resulting vacancy”
CENTENE CORP shareholders rejected Shareholder proposal for managing climate risk through science-based targets and transition planning at the 2024-05-14 meeting.
“4. Shareholder proposal for managing climate risk through science-based targets and transition planning. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes 171,606,594 303,602,455 2,859,738 16,990,125”
CENTENE CORP shareholders approved Ratification of the appointment of KPMG LLP at the 2024-05-14 meeting.
“3. Ratification of the appointment of KPMG LLP. The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 was ratified based upon the following votes: For Against Abstain 484,315,258 10,457,390 286,264”
CENTENE CORP shareholders approved Non-binding advisory vote on executive compensation at the 2024-05-14 meeting.
“2. Non-binding advisory vote on executive compensation. The Company's executive compensation was approved by a non-binding advisory vote based upon the following votes: For Against Abstain Broker Non-Votes 433,825,369 43,973,709 269,709 16,990,125”
CENTENE CORP shareholders approved Election of Directors at the 2024-05-14 meeting.
“1. Election of Directors. The ten directors were elected at the Annual Meeting for a one-year term based upon the following votes:”
CENTENE CORP reported the first quarter ended March 31, 2024 results: revenue Total revenues (in millions) $ 40,407, EPS GAAP diluted EPS $ 2.16. Guidance raised.
“announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 first quarter results were as follows: Total revenues (in millions) $ 40,407 Premium and service revenues (in millions) $ 36,337 Health benefits ratio 87.1 % SG&A expense ratio 8.9 % Adjusted SG&A expense ratio (1) 8.7 % GAAP diluted EPS $ 2.16 Adjusted”
James E. Murray retired as other at CENTENE CORP.
“James E. Murray has retired from the Company effective March 29, 2024.”
CENTENE CORP reported fourth quarter and year ended December 31, 2023 results: revenue Premium and service revenues (in millions) $ 35,338 $ 140,095.
“as follows: 2023 Results Q4 Full Year Total revenues (in millions) $ 39,460 $ 153,999 Premium and service revenues (in millions) $ 35,338 $ 140,095 Health benefits ratio 89.5 % 87.7 % SG&A expense ratio 9.9 % 9.0 % Adjusted SG&A expense ratio (1) 9.7 % 8.9 % GAAP diluted EPS $ 0.08 $ 4.95 Adjusted diluted EPS (1) $ 0.45 $ 6.68 Total cash flow provided by operations (in millions) $ 217 $ 8,053 (1) Represents a non-GAAP financial measure.”
CENTENE CORP: Amendments to By-Laws to revise and clarify procedural and disclosure requirements for stockholder special meetings, nominations, and business proposals, and to update for Delaware law changes (effective 2023-12-08).
“On December 8, 2023, the Board of Directors (the "Board") of Centene Corporation (the "Company") approved and adopted amendments (the "Amendments") to the Company’s Amended and Restated By-Laws (the "By-Laws").”
Susan Smith was appointed as Chief Operating Officer at CENTENE CORP.
“On November 15, 2023, Centene Corporation (the “Company”) announced that Susan Smith, 48, will be appointed as the Company’s Chief Operating Officer, effective January 1, 2024.”
CENTENE CORP updated its the third quarter ended September 30, 2023 guidance (raised).
“On October 24, 2023, we issued a press release announcing our financial results for the third quarter ended September 30, 2023.”
CENTENE CORP reported second quarter ended June 30, 2023 results: revenue $34.8 billion, net income Diluted EPS of $1.92, EPS Adjusted diluted EPS of $2.10. Guidance raised.
“EPS of $2.10 -- -- Increases 2023 Full Year Guidance -- • Adjusted diluted EPS of $2.10, up over 18% from $1.77 in the second quarter of 2022. • Premium and service revenues of $34.8 billion in the second quarter of 2023. • Medicaid redeterminations progressing as expected. • Increases 2023 full year adjusted diluted EPS guidance by $0.05 to at least $6.45;”
CENTENE CORP amended First Amendment with Wells Fargo Bank, National Association (effective 2023-05-31).
“On May 31, 2023, Centene Corporation (the “Company”) entered into a first amendment (the “First Amendment”) to the Company’s Fourth Amended and Restated Credit Agreement”
James E. Murray departed as Chief Operating Officer at CENTENE CORP.
“On May 19, 2023, James E. Murray, Chief Operating Officer (“COO”), formally notified the Company of his plans to retire in 2024.”
CENTENE CORP shareholders rejected Shareholder proposal for maternal morbidity reduction metrics in executive compensation at the 2023-05-10 meeting.
“6. Shareholder proposal for maternal morbidity reduction metrics in executive compensation. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes 59,585,452 422,734,550 3,964,431 20,912,098”
CENTENE CORP shareholders rejected Shareholder proposal for shareholder ratification of termination pay at the 2023-05-10 meeting.
“5. Shareholder proposal for shareholder ratification of termination pay. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes 44,697,030 441,040,108 547,295 20,912,098”
CENTENE CORP shareholders approved Ratification of the appointment of KPMG LLP at the 2023-05-10 meeting.
“4. Ratification of the appointment of KPMG LLP. The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified based upon the following votes: For Against Abstain 496,331,179 10,734,626 130,726”
CENTENE CORP shareholders approved Non-binding advisory vote on frequency of future advisory votes on executive compensation at the 2023-05-10 meeting.
“3. Non-binding advisory vote on frequency of future advisory votes on executive compensation. The frequency of future advisory votes on executive compensation was 1 Year based upon the following votes: 1 Year 2 Years 3 Years Abstain 479,944,774 118,020 6,058,224 163,415”
CENTENE CORP shareholders approved Non-binding advisory vote on executive compensation at the 2023-05-10 meeting.
“2. Non-binding advisory vote on executive compensation. The Company's executive compensation was approved by a non-binding advisory vote based upon the following votes: For Against Abstain Broker Non-Votes 408,119,178 77,813,537 351,718 20,912,098”
CENTENE CORP shareholders approved Election of Directors at the 2023-05-10 meeting.
“1. Election of Directors. The ten directors were elected at the Annual Meeting for a one-year term based upon the following votes: Director Nominee For Against Abstain Broker Non-Votes Jessica L. Blume 464,810,199 8,694,829 12,779,405 20,912,098 Kenneth A. Burdick 480,536,857 5,525,016 222,560 20,912,098 Christopher J. Coughlin 452,841,750 20,677,665 12,765,018 20,912,098 H. James Dallas 468,870,076 4,645,599 12,768,758 20,912,098 Wayne S. DeVeydt 469,994,883 16,126,335 163,215 20,912,098 Frederick H. Eppinger 457,080,119 28,858,030 346,284 20,912,098 Monte E. Ford 478,985,615 7,057,667 241,151 20,912,098 Sarah M. London 481,688,450 4,335,436 260,547 20,912,098 Lori J. Robinson 455,742,066 17,601,889 12,940,478 20,912,098 Theodore R. Samuels 457,394,435 16,026,058 12,863,940 20,912,098”
CENTENE CORP reported the first quarter ended March 31, 2023 results: revenue $35.0 billion, EPS $2.04. Guidance raised.
“CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS -- Diluted E PS of $2.04; Adjusted Diluted EPS of $2.11 -- -- Increases 2023 Full Year Guidance and Updates 2024 Target -- • Increased 2023 full year Adjusted EPS guidance to at least $6.40 driven by strong performance in its market leading Medicaid and Marketplace businesses. • Premium and service revenues of $35.0 billion in the first quarter of 2023.”
CENTENE CORP reported year ended December 31, 2022 results: revenue $144,547, EPS $2.07. Guidance raised.
“In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78”
CENTENE CORP reported fourth quarter ended December 31, 2022 results: revenue $35,561, EPS $ (0.38). Guidance raised.
“In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78”
Brent Layton changed role as Senior Advisor to the Chief Executive Officer at CENTENE CORP.
“Brent Layton, the Company’s current President and Chief Operating Officer, will transition to the role of Senior Advisor to the Chief Executive Officer as a non-executive officer until his planned retirement on December 31, 2023.”
James Murray was appointed as Executive Vice President, Chief Operating Officer at CENTENE CORP.
“announced that the Board of Directors of the Company had appointed Kenneth Fasola, 63, as President of the Company and James Murray, 69, as Executive Vice President, Chief Operating Officer of the Company effective as of December 14, 2022.”
Kenneth Fasola was appointed as President at CENTENE CORP.
“announced that the Board of Directors of the Company had appointed Kenneth Fasola, 63, as President of the Company and James Murray, 69, as Executive Vice President, Chief Operating Officer of the Company effective as of December 14, 2022.”
Monte Ford was elected as Director at CENTENE CORP.
“On November 12, 2022, the board of directors (the “ Board ”) of Centene Corporation (the “ Company ”) elected Monte Ford to the Board”
Leslie Norwalk resigned as member of the board of directors at CENTENE CORP.
“On April 11, 2022, Leslie Norwalk resigned, effective immediately, as a member of the board of the directors (the “Board”) of Centene Corporation (the “Company”).”
Michael F. Neidorff departed as Chief Executive Officer at CENTENE CORP.
“On March 21, 2022, the Board of Directors (the “ Board ”) of Centene Corporation (the “ Company ”) appointed Sarah M. London, currently the Company’s Vice Chairman and member of the Office of the Chairman, to the position of Chief Executive Officer of the Company, effective immediately, succeeding of Michael F. Neidorff.”
Sarah M. London was appointed as Chief Executive Officer at CENTENE CORP.
“On March 21, 2022, the Board of Directors (the “ Board ”) of Centene Corporation (the “ Company ”) appointed Sarah M. London, currently the Company’s Vice Chairman and member of the Office of the Chairman, to the position of Chief Executive Officer of the Company, effective immediately, succeeding of Michael F. Neidorff.”
James Dallas was appointed as Acting Chairman at CENTENE CORP.
“The Board also (i) appointed James Dallas as the Acting Chairman of the Board”
Michael Neidorff changed role as Chief Executive Officer, Chairman, and Director at CENTENE CORP.
“On February 23, 2022, the Board of Directors (the “Board”) of Centene Corporation (the “Company”) approved a request from Michael Neidorff for a paid medical leave of absence from his roles as Chief Executive Officer, Chairman, and a director of the Company (the “Leave of Absence”).”
Leslie Norwalk was elected as Director at CENTENE CORP.
“On January 11, 2022, the board of directors of the Company (the “Board”) elected Ms. Norwalk to the Board as a Class II director, with a term expiring at the Company’s 2024 annual meeting of stockholders, and appointed her to the Board’s Compliance Committee, Environmental and Social Responsibility Committee and Government and Regulatory Affairs Committee.”
Coughlin was appointed as director at CENTENE CORP.
“Other than the Agreement, there is no other arrangement or understanding pursuant to which Messrs. Burdick, Samuels, DeVeydt and Coughlin will be appointed as a director of the Company.”
DeVeydt was appointed as director at CENTENE CORP.
“Other than the Agreement, there is no other arrangement or understanding pursuant to which Messrs. Burdick, Samuels, DeVeydt and Coughlin will be appointed as a director of the Company.”
Samuels was appointed as director at CENTENE CORP.
“Other than the Agreement, there is no other arrangement or understanding pursuant to which Messrs. Burdick, Samuels, DeVeydt and Coughlin will be appointed as a director of the Company.”
Ken Burdick was appointed as director at CENTENE CORP.
“Other than the Agreement, there is no other arrangement or understanding pursuant to which Messrs. Burdick, Samuels, DeVeydt and Coughlin will be appointed as a director of the Company.”
Tommy Thompson departed as director at CENTENE CORP.
“Upon their retirement, it is expected that each of Messrs. Ditmore, Roberts and Thompson will be designated as a nonvoting director emeritus through the Company’s 2022 annual meeting, in the case of Messrs. Roberts and Thompson, and through the Company’s 2023 annual meeting, in the case of Mr. Ditmore.”
John Roberts departed as director at CENTENE CORP.
“Upon their retirement, it is expected that each of Messrs. Ditmore, Roberts and Thompson will be designated as a nonvoting director emeritus through the Company’s 2022 annual meeting, in the case of Messrs. Roberts and Thompson, and through the Company’s 2023 annual meeting, in the case of Mr. Ditmore.”
Robert Ditmore departed as director at CENTENE CORP.
“Upon their retirement, it is expected that each of Messrs. Ditmore, Roberts and Thompson will be designated as a nonvoting director emeritus through the Company’s 2022 annual meeting, in the case of Messrs. Roberts and Thompson, and through the Company’s 2023 annual meeting, in the case of Mr. Ditmore.”
Michael Neidorff changed role as Executive Chairman at CENTENE CORP.
“Mr. Neidorff has informed the Board that he plans to retire as Chief Executive Officer of the Company. Mr. Neidorff will serve as Executive Chairman throughout the remainder of 2022, upon his retirement as Chief Executive Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.